These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6811006)

  • 1. Nebulised salbutamol and angina.
    Neville E; Corris PA; Vivian J; Nariman S; Gibson GJ
    Br Med J (Clin Res Ed); 1982 Sep; 285(6344):796-7. PubMed ID: 6811006
    [No Abstract]   [Full Text] [Related]  

  • 2. [Side-effects of beta-adrenergic drugs].
    Mancini G; Mannino F
    Minerva Med; 1976 Mar; 67(15):974-7. PubMed ID: 4752
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute carbon dioxide narcosis during inhalational therapy with oxygen powered nebulizers in patients with chronic airflow limitation.
    Lim TK; Tan WC
    Ann Acad Med Singap; 1985 Jul; 14(3):439-41. PubMed ID: 4073810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential hazard of nebulised salbutamol in patients with haemoptysis.
    Ullah MI; Fegan O
    Br Med J (Clin Res Ed); 1983 Mar; 286(6368):844-5. PubMed ID: 6403108
    [No Abstract]   [Full Text] [Related]  

  • 5. Unsuspected coronary artery disease revealed by administration of nebulised salbutamol.
    Montgomery HE; Gill J; Pumphrey CW
    Br Heart J; 1994 Aug; 72(2):181. PubMed ID: 7917693
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol.
    Humphreys DM
    BMJ; 1992 Feb; 304(6822):320. PubMed ID: 1531432
    [No Abstract]   [Full Text] [Related]  

  • 7. Experiences with large doses of beta 2-agonists inhaled from nebulizers.
    Larsson S
    Postgrad Med J; 1983; 59 Suppl 3():71-2. PubMed ID: 6647211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease.
    Crane J; Burgess CD; Graham AN; Maling TJ
    N Z Med J; 1987 May; 100(824):309-11. PubMed ID: 3330186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Haleraid in rheumatoid arthritis with obstructive lung disease.
    Wolstenholme RJ; Shettar SP; Taher F; Hatton B
    Br J Rheumatol; 1986 Aug; 25(3):318. PubMed ID: 3730748
    [No Abstract]   [Full Text] [Related]  

  • 10. Salbutamol and cardiac arrhythmias.
    Crawford SM; Miles DW
    Curr Med Res Opin; 1981; 7(6):410-5. PubMed ID: 7238086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Salbutamol in the treatment of functional broncho-obstructive syndromes].
    Fiora L
    Minerva Med; 1976 Apr; 67(17):1165-75. PubMed ID: 1264395
    [No Abstract]   [Full Text] [Related]  

  • 12. ABC of blood pressure reduction: special problems.
    Bannan LT; Beevers DG; Jackson SH; Wright N
    Br Med J; 1980 Nov; 281(6249):1200-2. PubMed ID: 7427633
    [No Abstract]   [Full Text] [Related]  

  • 13. Air-driven nebulised high-dose salbutamol in severe chronic obstructive airways disease: is it safe?
    Lai CK; Legge JS; Friend JA
    Respiration; 1991; 58(5-6):249-54. PubMed ID: 1792412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of nebulised and inhaled salbutamol on breathlessness in severe COPD.
    Poole PJ; Saini R; Brodie SM; Black PN
    Respir Med; 2005 Mar; 99(3):372-6. PubMed ID: 15733514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Salbutamol in the treatment of severe broncho-asthmatic attacks].
    Ruggerini R; Romitti M; Sprocato S; Bianco F
    Minerva Anestesiol; 1977 Apr; 43(4):239-43. PubMed ID: 876464
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease].
    Bauer K; Lorenz PR; Seibel K; Neiss A; Eandi M; Kaik G
    Arzneimittelforschung; 1989 Jul; 39(7):801-4. PubMed ID: 2675854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the bronchodilator action of salbutamol and orciprenaline by aerosol administration in patients with chronic bronchopneumopathy].
    Sorbini CA; Todisco T; Boschetti E
    Minerva Med; 1976 Mar; 67(16):1079-83. PubMed ID: 1264384
    [No Abstract]   [Full Text] [Related]  

  • 18. Nebulised ipratropium and salbutamol in asthma.
    Storr J; Lenney W
    Arch Dis Child; 1986 Jun; 61(6):602-3. PubMed ID: 2942116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bronchodilator action and side effects of salbutamol in patients with bronchospasm of the respiratory tract].
    Cesco G
    Minerva Med; 1976 Apr; 67(17):1151-4. PubMed ID: 1264393
    [No Abstract]   [Full Text] [Related]  

  • 20. Nebulised salbutamol challenge confirming life-threatening paradoxical bronchospasm.
    Zhong G; Shen NY; Sammut J
    Emerg Med Australas; 2014 Apr; 26(2):202-3. PubMed ID: 24708015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.